13 / 1481
PET Impact: Staging & Management
Dizendorf et al. J Nuc Med 2003
Changes in XRT management (TVD, dose or therapy intent)
Diagnosis (Ca)
Case (N)
Mx Change (N)
Mx Change (%)
H & N
55
18
33
Gyn
28
9
32
Breast
28
7
25
Lung
26
8
31
Lymphoma
24
5
21
GI
18
4
22
Unknown Prim
4
3
75
Melanoma
2
1
50
Other Ca
17
0
0
Total
202
55
27